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c-Myc (Myc) is an important transcriptional regulator
in embryonic stem (ES) cells, somatic cell reprogram-
ming, and cancer. Here, we identify a Myc-centered
regulatory network in ES cells by combining pro-
tein-protein and protein-DNA interaction studies
and show that Myc interacts with the NuA4 complex,
a regulator of ES cell identity. In combination with
regulatory network information, we define three ES
cell modules (Core, Polycomb, and Myc) and show
that the modules are functionally separable, illus-
trating that the overall ES cell transcription program
is composed of distinct units. With these modules
as an analytical tool, we have reassessed the hypoth-
esis linking an ES cell signature with cancer or cancer
stem cells. We find that the Myc module, indepen-
dent of the Core module, is active in various cancers
and predicts cancer outcome. The apparent simi-
larity of cancer and ES cell signatures reflects, in
large part, the pervasive nature of Myc regulatory
networks.
INTRODUCTION
The pluripotent state of embryonic stem (ES) cells is maintained
through the combinatorial actions of core transcription factors,
including Oct4, Sox2, and Nanog (Boyer et al., 2005; Chen
et al., 2008; Kim et al., 2008; Loh et al., 2006), in addition to other
regulatory mechanisms encompassing epigenetic regulation
(Boyer et al., 2006; Lee et al., 2006), microRNAs (Marson et al.,
2008; Melton et al., 2010), and signaling pathways (Niwa et al.,
1998; Sato et al., 2004). The discovery that cocktails of core
pluripotency factors and selected widely expressed factors,
such as Myc and Lin28, reprogram differentiated cells to an
ES-like state (Park et al., 2008; Takahashi and Yamanaka,2006; Yu et al., 2007) underscores the central role of transcrip-
tion factors in cell fate decisions (Graf and Enver, 2009). Compre-
hensive protein interaction and target gene assessment of core
pluripotency factors has provided a framework for conceptual-
izing the regulatory network that supports the ES cell state.
Striking among the features of this network is the extent to which
the core factors physically associate within protein complexes,
co-occupy target genes, and cross-regulate each other (Boyer
et al., 2005; Chen et al., 2008; Kim et al., 2008; Loh et al.,
2006; Wang et al., 2006).
Although its expression dramatically enhances induced
pluripotent (iPS) cell formation, Myc is not an integral member
of the core pluripotency network (Chen et al., 2008; Hu et al.,
2009; Kim et al., 2008). Myc occupies considerably more
genomic target genes than the core factors, and Myc targets
are involved predominantly in cellular metabolism, cell cycle,
and protein synthesis pathways, whereas the targets of core
factors relate more toward developmental and transcription-
associated processes (Kim et al., 2008). Interestingly, promoters
occupied by Myc show a strong correlation with a histone H3
lysine 4 trimethylation (H3K4me3) signature and a reverse corre-
lation with histone H3 lysine 27 trimethylation (H3K27me3), sug-
gesting a connection between Myc and epigenetic regulation
(Kim et al., 2008). It is notable that the H3K4me3 signature has
a positive correlation with active genes, and an open chromo-
somal structure, a distinctive feature of ES cells (Meshorer
et al., 2006). Studies in non-ES cells have also revealed that
Myc interacts with histone acetyltransferases (HATs) (Doyon
and Coˆte´, 2004; Frank et al., 2003). Improved iPS cell generation
by addition of histone deacetylase inhibitors implies that global
changes in epigenetic signatures are critical to efficient somatic
cell reprogramming (Huangfu et al., 2008).
Although they remain pluripotent, ES cells are capable of indef-
inite self-renewal. Both blocked differentiation and the capacity
for self-renewal, hallmarks of ES cells and adult stem cells, are
shared in part by cancer cells (Clarke and Fuller, 2006; Reya
et al., 2001). Although contested in the literature, expression of
pluripotency factors, such as Oct4 and Nanog, has beenCell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc. 313
described in some cancers (Kang et al., 2009; Schoenhals et al.,
2009). The involvement of Myc in many cancers (Cole and
Henriksson, 2006) and its effects in iPS cell generation raise
important issues regarding the relationship between cancer
and embryonic stem cell states. Moreover, renewed focus on
tumor subpopulations that initiate tumor formation on transfer
to a suitable host (cancer stem cells) has contributed to the
comparison of cancers and stemcells and to thepotential resem-
blance of metastatic cancer cells to stem cells.
These relationships have been reinforced by reports of ‘‘stem
cell’’ or ‘‘embryonic stem cell’’ (ESC)–like signatures in human
and mouse cancers (Ben-Porath et al., 2008; Wong et al.,
2008a; Wong et al., 2008b). The properties of such ESC-like
signatures have thus far not been clearly defined, leaving open
the possibility that they are composed of multiple gene expres-
sion signatures that are the outcomes of functionally indepen-
dent transcriptional regulatory networks. Cancer cells may
share only one or few of these subdivided signatures observed
in ES cells, and thus have relatively less in common with the
‘‘embryonic state’’ than recently suggested.
In the present study, we sought to define how the regulatory
network controlled by Myc relates to the previously defined
core pluripotency network (Boyer et al., 2005; Chen et al.,
2008; Kim et al., 2008; Loh et al., 2006). We first identified
a Myc-centered regulatory network in ES cells and revealed
that this Myc-centered network is largely independent of the
core ES cell pluripotency network. On the basis of these findings,
we propose that the overall ES cell specific gene expression
signature is composed of smaller sets of subsignatures, which
are represented as ‘‘modules’’—modules for the core pluripo-
tency factors (Core module), the Polycomb complex factors
(PRC module), and the Myc-related factors (Myc module). We
provide evidence that these modules are functionally indepen-
dent in ES cells, as well as during somatic cell reprogramming.
With these modules as analytical tools, we observe that ES cells
and cancer cells share Myc module activity, but generally do not
share Core module activity. These findings argue against the
hypothesis that cancer cells often reactivate an embryonic
stem cell gene signature, even as they progress to a more highly
invasive or metastatic state. Instead, the common features of ES
cells and cancer cells reflect in large part the pervasive nature of
the Myc regulatory network.
RESULTS
Construction of a Myc-Centered Protein-Protein
Interaction Network in ES Cells
Previous protein-DNA interaction studies in ES cells indicated
that targets occupied by the core pluripotency factors differ
from genes bound by Myc (Chen et al., 2008; Kim et al., 2008).
A recent RNA interference–based functional screen additionally
suggested the existence of a second network linked functionally
with Myc (Hu et al., 2009). Because coregulators that function
with Myc have not been characterized previously in ES cells,
we first sought to identify protein complexes that contain Myc
with Myc-associated factors in ES cells. Using the in vivo meta-
bolic biotin tagging method (de Boer et al., 2003; Wang et al.,
2006), protein complexes containing tagged Myc in ES cells314 Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc.were affinity purified and analyzed by mass-spectrometry. We
identified several proteins known to interact with Myc in other
cell types, including Max, Ep400, Dmap1, and Trrap (Figure 1A)
(Cai et al., 2003; Fuchs et al., 2001; McMahon et al., 1998). To
expand and validate the protein-protein interaction network
encompassing Myc, we subsequently generated ES cell lines
expressing tagged Max and tagged Dmap1. ES cells expressing
tagged Tip60 and tagged Gcn5 were also generated because
they are HATs and known interacting partners of Trrap (Ikura
et al., 2000; McMahon et al., 2000). We also generated tagged
E2F4 ES cells, because another E2F family member E2F1 shares
many common targets with Myc (Chen et al., 2008). E2F1 and
E2F4 have many common targets and interchangeable roles in
normal and tumor cells (Xu et al., 2007). Among E2F family
proteins, E2F4 shows strongest expression in ES cells. In
summary, we established ES cell lines expressing tagged Myc,
Max, Dmap1, Tip60, Gcn5, and E2F4 (Figure 1A and Figure S1A
available online) and identified their interacting partner pro-
teins (summarized in Table S1). Figure 1A shows lists of high
confidence interacting partner proteins of each factor tested.
Interactions were independently validated by coimmunoprecipi-
tation (Figure 1C and Figure S1B).
Myc Interacts with the NuA4 HAT Complex in ES Cells
We did not observe overlap of proteins existing between the
core protein interaction network (Wang et al., 2006) and the
Myc-centered protein interaction network (Figure S1C).
Although this may be due to the stringency of our conditions
for recovery of protein complexes, within each network we
observed a high degree of interactions, strongly suggesting
that these two networks, and their protein complexes, are phys-
ically separate. Interestingly, we observed that Myc interacts
with many proteins in a recognized conserved protein complex
known as NuA4 HAT (or the Tip60-Ep400 complex) (Doyon and
Coˆte´, 2004) as shown in Figure 1A (pink cells) and Figure 1B
(proteins in a pink circle). Myc, Max, Dmap1, Tip60, Trrap, and
Ep400 are tightly interconnected within the network; however,
Gcn5 and E2F4 show a lower degree of association, suggesting
their weak or indirect interaction with Myc/NuA4. It has been
suggested that transcription factors, such as Myc, p53, and
E2Fs, require the NuA4 complex to activate downstream targets
in non-ES cell contexts (Ard et al., 2002; McMahon et al., 1998).
Our data (Figure 1 and Table S1) strongly support the view that
Myc interacts with an intact NuA4 HAT complex in ES cells,
also implying that histone 3 and 4 acetylation (AcH3 and AcH4,
respectively) signatures may also be generated in part by the
Myc/NuA4 complex via Tip60 in ES cells. Previous RNAi-based
phenotypic analyses in ES cells revealed that factors in the
NuA4 HAT complex, including Ep400, Dmap1, Tip60, Trrap,
Ruvb1, and Ruvb2, are critical to ES cell identity (Fazzio et al.,
2008) (also our observation, Figures S1D and S1E). These find-
ings imply a crucial role for the Myc/NuA4 complex in ES cells.
Construction of a Myc-Centered Protein-DNA
Interaction Network in ES Cells
To identify genomic targets of Myc and its associated factors
tested in Figure 1, we performed bioChIP-chip (Kim et al.,
2008). Because Tip60 and Gcn5 generate AcH3 and AcH4
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Figure 1. Myc-Centered Protein-Protein Interaction Network in ES Cells
(A) Schematic representation of the strategy for mapping a Myc-centered protein-protein interaction network in ES cells. High-confidence components of
multiprotein complexes were identified and listed in the table. Pink cells represent NuA4 complex proteins.
(B) Depiction of the features of the Myc-centered protein-protein interaction network. Proteins with green labels are biotin tagged proteins and pink circles
indicate NuA4 complex proteins. Proteins identified by multiple biotin-tagged factors are shown. Entire protein interaction network is shown in Figure S1C.
See also Table S1.
(C) Validation of the interaction network by coimmunoprecipitation.histone modification signatures, we also performed ChIP reac-
tions using native antibodies against AcH3 and AcH4. We found
that the six factors we tested (Myc, Max, Dmap1, Tip60, E2F4,
and Gcn5) co-occupy many target promoters in close proximity
(Figure 2A).To obtain a global view of individual and multiple transcription
factor occupancy, we combined this new data set with previ-
ously published ChIP-chip or ChIP-sequencing data sets (Boyer
et al., 2006; Chen et al., 2008; Ding et al., 2009; Hu et al., 2009;
Kim et al., 2008; Shen et al., 2008) and tested the factorCell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc. 315
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Figure 2. Myc-Centered Protein-DNA Interaction Network in ES Cells
(A) Representative view of Myc, Max, Dmap1, Tip60, E2F4, and Gcn5 occupancy at the target loci.
(B) Number of target promoters bound by each factor or associated with each histone modification signature. Blue represents factors or histone signatures
involved in PRC complexes. Red represents factors involved in ES cell core factors, and green represents Myc and Myc- related factors or histone signatures
(D and E). See also Figure S2 and Table S2.
(C) Relative position of chromosomal target loci of each factor in the Myc cluster (upper panel) and Core cluster (bottom panel) shown in (B) and (C) to the TSS.
(D) Target correlation map: The degree of target co-occupancy of each pair of factors (either transcription factor or histone modification signature) is shown.
Yellow indicates more frequent colocalization of each pair of factors.
(E) Median distance map: Median distances between the loci co-occupied by two tested factors (except PRC complex proteins) shown in (D). Yellow indicates
closer colocalization.occupancy or histone modification signatures (see Supple-
mental Information). The numbers of genes that are occupied
by a tested factor or marked by a tested histone modification
signature are summarized in Figure 2B and Table S2 with a hier-
archical clustering image based on target co-occupancy. We
then calculated the degree of target co-occupancy of each
pair of factors. As shown in the target correlation map in
Figure 2D, we observed three major clusters. Factors in Poly-
comb complexes are associated with the H3K27me3 signature
to form a distinct cluster (PRC cluster, blue-colored box in
Figure 2D and blue letters in Figures 2B and 2D). Core pluripo-
tency factors, including Nanog, Sox2, and Oct4 and others,
form an independent cluster (Core cluster, red-colored box
and red letters). Myc forms a cluster with other factors and
AcH3, AcH4, and H3K4me3 signatures (Myc cluster, green-
colored box and green letters).
We calculated the median distances between binding peaks
of each pair of factors using the same cluster information shown316 Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc.in Figure 2D (except for the PRC cluster because of availability of
the processed data). The target distance map demonstrates
that the factors within the Core or Myc clusters regulate their
common targets in close proximity, whereas the factors
belonging to a different cluster regulate their common targets
in a relatively remote manner (Figure 2E).
Previously, we observed that Myc occupiesmore target genes
than the ES cell core factors (Kim et al., 2008). Similarly, we
observed that the factors in the Myc cluster, such as Max,
nMyc, E2F4, and Dmap1, tend to occupy more targets than
factors in the Core or PRC clusters (Figure 2B), suggesting
more global roles in their target gene regulation. The majority
of binding peaks generated by the factors in the Myc cluster
are more centered at the transcription start site (TSS) compared
to the target binding peaks of the factors in the Core cluster
(Figure 2C). The factors in the Myc cluster may interact with
basal transcription machinery, whereas core factors have both
promoter and upstream enhancer targets, as described
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Figure 3. Histone Modification Signatures on the Target Promoters
of Myc Cluster Proteins
(A) Histone marks on the target promoters of each factor in the Myc cluster.
‘‘All’’ represents all promoters.
(B) Histone marks and target co-occupancy of seven factors in Myc cluster
(Myc, Max, nMyc, Dmap1, E2F1, E2F4, and Zfx).elsewhere (Chen et al., 2008; Loh et al., 2006). In summary, our
data suggest that the factors belonging to each of the distinct
clusters (Core, PRC, and Myc) regulate their own rather similar
downstream targets in close proximity and may be functionally
separated in regulating aspects of ES cell identity.
Target Co-occupancy of Factors within the Myc Cluster
Has a Positive Correlation with Histone H3 and H4
Acetylation Signatures
Our prior work revealed that Myc target promoters correlate
positively with an active H3K4me3 signature and negatively
with a repressive H3K27me3 signature (Kim et al., 2008).
Because Myc is associated with histone acetylation (Frank
et al., 2001), we tested the correlation between target occupancy
of each factor in the Myc cluster and the histone modification
status of their target promoters. As shown in Figure 3A, the
majority of the factors in the Myc cluster harbor significantly
higher levels of H3K4me3, AcH3, and AcH4 signatures on their
target promoters over background (at least >150%). On the
contrary, the H3K27me3 signature is significantly underrepre-
sented on the target promoters of approximately half of the
factors in the Myc cluster. Interestingly, Cnot3 and Trim28 target
promoters show bivalent modifications (both H3K4me3 and
H3K27me3 positive), suggesting that, although these factors
share many common targets with Myc, they may have different
functions compared to the other factors in the cluster.
Additionally, we tested the relationship between the factor co-
occupancy (seven factors in theMyc cluster shown in Figures 2Dand 2E, includingMyc,Max, nMyc, Dmap1, E2F1, E2F4, and Zfx)
and histone modification signatures. As shown in Figure 3B,
target promoters co-occupied by multiple factors in the Myc
cluster show a higher level of histone acetylation than the
common targets of fewer factors. Targets occupied by seven
factors show approximately 400% and 220% of AcH4 and
AcH3 signatures, respectively, over the background level.
Upon the decrease of co-occupancy, the level of these signa-
tures decreased on their common targets. We failed to observe
correlation between co-occupancy and the H3K4me3 signature,
presumably as a result of the abundance of H3K4me3 marks
across many promoters (>60% of all promoters) (Kim et al.,
2008). The repressive signature H3K27me3 displays a reverse
correlationwith theMyc cluster factor co-occupancy (Figure 3B).
Modules Defined by Transcriptional Regulatory
Subnetworks in ES Cells
Because we observed a strong positive correlation between
target co-occupancy of the factors in the Myc cluster and
histone acetylation signatures, we examined the correlation
between target co-occupancy and gene expression. As shown
in Figure 4A, targets co-occupied by seven or six factors in the
Myc cluster are more active than the common targets of five or
fewer factors in ES cells (red line) and are repressed upon differ-
entiation (blue line). To test whether the information generated
from the factor co-occupancy in the Myc cluster is functionally
relevant, we compared KEGG pathways (Dennis et al., 2003;
Ogata et al., 1999) enriched in the genes that are common
targets of at least six factors among seven factors in the Myc
cluster (Myc, Max, nMyc, Dmap1, E2F1, E2F4, and Zfx; black
bar in Figure 4A) and the global target genes of Myc. Many
cancer-related pathways (red letters in Figure 4B and Table S3)
are enriched in the genes co-occupied by the factors in the Myc
cluster. In contrast, these cancer-related pathways are not
enriched within the global set of genes occupied by Myc. This
observation strongly suggests that factor co-occupancy in the
Myc cluster does not represent a random subset of Myc targets
and may provide additional information in understanding the
combinatorial function of factors in the Myc cluster in ES cells
and in cancer cells (Figure 4B).
We previously demonstrated that common targets of multiple
factors in the core pluripotency network are significantly active
in ES cells. However, when these factors occupy targets alone
or with few factors, they are not associated with activation of
target genes (Kim et al., 2008). Because the targets co-occupied
by seven factors in the Myc cluster show the strongest gene
activity (Figure 3B and Figure 4A), we classified common target
gene modules in ES cells according to the target co-occupancy
within the clusters shown in Figure 2; the PRC module, the
Core module, and the Myc module (Figure 4C and listed in
Table S3). The definition of each module is as follows; the Core
module is composed of genes co-occupied by at least seven
factors among nine factors shown in the Core cluster (Smad1,
Stat3, Klf4, Oct4, Nanog, Sox2, Nac1, Zfp281, and Dax1), de-
picted in the red box in Figure 2D. The PRC module genes are
the common targets of PRC cluster proteins, Suz12, Eed, Phc1,
and Rnf2 (blue box in Figure 2D). The Myc module is composed
of genes that are common targets of seven factors (Myc, Max,Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc. 317
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Figure 4. ES Cell Modules
(A) Gene expression profiles (log2, left y axis) upon J1 ES cell differentiation (wild-type ES cells: ES, differentiated ES cells for 14 days: dES day 14) are shown as
moving window averaged lines (ES; red line, dES day 14; blue line, bin size 100 and step size 1). Randomized genes are sorted (x axis) by the target co-occupancy
of seven factors in theMyc cluster (right y axis). Black bar represents target genes co-occupied by at least six factors among the seven factors in the Myc cluster.
(B) Enrichment of KEGG pathways. All Myc target genes (gray bars, total 3733 genes) and genes co-occupied by at least six factors among the seven factors
tested marked by black bar in (A) (black bars, total 1756 genes). See also Figures S3A and S3B and Table S3.
(C) ES cell modules: Three ES cell modules are defined based on the target co-occupancy within each cluster shown in Figure 2D. See also Table S3.
(D) GSEA analyses show the gene activity of the three ES cell modules (Core, PRC, and Myc modules) as well as the previously defined ESC-like module
(Wong et al., 2008a) upon ES cell differentiation (wild-type ES cells; ES versus 14 days differentiated ES cells; dES).
(E) Average gene expression values (log2) of eachmodule (C) are tested upon ES cell differentiation (ES day0, dES day2, dES day7, and dES day14, respectively).
Data are represented as mean ± SEM. See also Figure S2B and Figure S3C.nMyc, Dmap1, E2F1, E2F4, and Zfx) in the Myc cluster (green
box in Figure 2D). For construction of the Myc module, we
excluded Tip60, Gcn5, and Rex1, because of their relatively318 Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc.small number of targets (Figure 2B), and Trim28 and Cnot3,
because of the bivalent signature on their target promoters
(Figure 3A) and the discrepancy of their target similarity within
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Figure 5. Module Activity in Various Cells
(A) Average gene expression values (log2) (Srid-
haran et al., 2009) of ES cell modules (Core, PRc,
and Myc) and previously defined ESC-like module
are tested in ES cells (ES), iPS cells (iPS), MEFs
(MEF), and partial iPS cells (piPS). See also
Figure S3D.
(B) Average gene expression values (log2) (Bild
et al., 2006) of each module tested in (A) upon
induction of Myc in human epithelial cells (Myc
induction) and in control cells (WT). Human ortho-
logs of genes in three ES cell modules are tested
(listed in Table S3) and data are represented as
mean ± SEM (A and B).the Myc cluster (Figure S2A). Additional gene sets co-occupied
by different combinations of factors in Myc cluster were also
tested but showed no significant difference, because the
majority of target genes among the tested sets are shared (see
below and Figure S2B). Lists of gene sets tested are summarized
in Table S3. Indeed, the Core module includes previously known
factors in core regulatory circuitry, such as Nanog, Oct4, Rest,
Sox2, Tcf3, and Rex1. The PRCmodule includes genes generally
repressed in ES cells, including Hox cluster genes. As shown in
Figure 4C, the overlap between eachmodule is minimal and they
are involved in different pathways (Figures S3A and S3B).
We then tested activity of each module (hereafter referred to
as ‘‘module activity,’’ the averaged expression of all genes in
each module in a given expression data set) in ES cells
compared with the module activity in differentiated cells. Gene
activity of a previously identified Core ESC-like gene module
(hereafter referred to as ‘‘ESC-like module’’) (Wong et al.,
2008a) was also tested. Gene set enrichment analysis (GSEA)
(Subramanian et al., 2005) revealed that the Core, Myc, and
previously identified ESC-like modules are highly active in ES
cells. As anticipated, the PRC module is repressed in ES cells
(Figure 4D). We additionally tested the activity of each module
during a time-course of ES cell differentiation. As shown in Fig-
ure 4E and Figure S3C, in ES cells the Core module is most
active, yet the Myc and ESC-like modules show some activity;
these modules become repressed with time during differentia-
tion, whereas the PRC module shows an opposite pattern.
Functional Separation of Core and Myc Modules
in Partial iPS Cells
Although we observed that both the Core and Myc modules are
active in ES cells, the genes that comprise the Core module are
distinct from those of the Myc module (Figure 4C). To test
whether the modules can be functionally separable, we tested
the module activity of our three ES cell modules, along with the
ESC-like module (Wong et al., 2008a) in other cell types,
including iPS cells, partial iPS (piPS) cells, andmouse embryonic
fibroblasts (MEFs). Global gene expression profiles of ES and iPS
cells are highly similar (Takahashi and Yamanaka, 2006). Relying
on a publicly available data set (Sridharan et al., 2009), we tested
whether the module activity is similar between ES and iPS cells.
Similar to the data shown in Figure 4E, the Core and Myc
modules are highly active in both ES and iPS cells (Figure 5A
and Figure S3D). The PRC module is inactive in both cell types,as expected. In MEFs, the module activity pattern is similar to
the module activity shown in differentiated ES cells shown in
Figure 4E, suggesting that strongly active Core and Myc
modules, as well as an inactive PRC module, may characterize
the pluripotent state of cells, such as ES and iPS cells.
Previous work has shown that piPS cells exist at an interme-
diate stage in the reprogramming process (Maherali et al.,
2007). The endogenous ES cell core regulators Oct4 and Nanog
are not reactivated in piPS cells, whereas they are reactivated in
fully reprogrammed iPS cells. To test whether the ES cell
modules we have defined are functionally separable in piPS
cells, we analyzed ES module activity using gene expression
data from piPS cells (Figure 5A and Figure S3D) (Sridharan
et al., 2009). We found that the activity of the Myc module in
piPS cells is comparable to that in ES cells and iPS cells, but
the Core module is not reactivated in piPS cells. These data
demonstrate that the regulatory modules defined in ES cells
may be considered functionally separable units, not arbitrary
subdivisions of the overall ES cell signature. Of particular note,
the ESC-like module (Wong et al., 2008a) shows similar module
activity to our Myc module, but not to the Core module in piPS
cells.
ES Cell Module Activity in Cancer
Others have described ESC-like gene modules (Wong et al.,
2008a) or ES-cell like gene expression signatures (Ben-Porath
et al., 2008) that have been widely used in assessment of cancer
gene signatures. With the three ES cell modules we defined as
new analytical tools, we readdress the relatedness of ES cell
and cancer gene signatures as a series of case studies. For
analyses of human data, human orthologs of mouse genes
were used (Table S3).
Myc Induction Does Not Activate the Core Module
in Human Epithelial Cells
We tested ESC-like modules (both Core ESC-like gene and
mouse ESC-like gene modules) (Wong et al., 2008a) and found
that they behave similarly to our Myc module in various settings
(Figure 4E, Figure 5A, and data not shown). Because we
observed that our defined Core and Myc modules can be func-
tionally separated in piPS cells (Figure 5A), we examinedwhether
the induction of Myc may activate the Core module in a different
cellular context. It has been reported previously that the induc-
tion of Myc activates the ESC-like module in adult humanCell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc. 319
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Figure 6. ES Cell Modules in Mouse MLL
Myeloid Leukemia Models
(A) Average gene expression values (log2) of ES
cell modules and the previously defined ESC-like
module are tested in various mouse models of
acute myeloid leukemia (AML) initiated by
MLL-AF9, MLL-ENL, MLL-AF10, MLL-AF1p, and
MLL-GAS7 (Somervaille et al., 2009).
(B) Average gene expression values (log2) of each
module are tested in a c-kit high MLL-AF10
leukemia cell population (MLL-AF10 c-kit high)
and a c-kit lowMLL-AF10 leukemia cell population
(MLL-AF10 c-kit low) (Somervaille et al., 2009).
Data are represented as mean ± SEM (A and B).
See also Figure S4.epithelial cells (Wong et al., 2008a). As shown in Figure 5B, upon
reanalysis of this data set (Bild et al., 2006), we find that the Core
module is not activated following Myc induction, whereas the
Myc module is strongly represented. In addition, core factors
in ES cells, such as Nanog and Oct4, are also not activated by
Myc induction (Figure S4A). These observations confirm that
the Myc and Core modules are functionally separable and also
support the view that the overall ES cell expression signature
can be subdivided into functionally distinct units. Our refined
analysis argues against the prior conclusion that Myc induction
leads to activation of an ESC-like gene module in human epithe-
lial cells (Wong et al., 2008a).
ES Cell Modules in Mouse MLL Myeloid Leukemia
Models
We have assessed the relevance of our ES cell modules within
a mouse model of acute myeloid leukemia (AML). Expression
of MLL alleles leading to expression of fusion products, such
as MLL-AF9, MLL-ENL, MLL-AF10, MLL-AF1p, and MLL-
GAS7, initiates leukemia. MLL-associated leukemia models in
mice have served as platforms for purifying and examining the
gene expression profiles of leukemia stem cells (LSCs, also
called leukemia-initiating cells) (Krivtsov et al., 2006). It has
also been suggested that LSCs are present at a higher frequency
in leukemic mice in which AML was initiated by MLL-ENL or
MLL-AF9 as compared with MLL-AF10, MLL-AF1p, and
MLL-GAS7 (Somervaille et al., 2009). We tested the activity of
our defined modules in these leukemias. We first observed that
the Core module is not active in any of the AMLs as compared
to the Core module activity of a control group (Figure 6A). More-
over, we failed to detect an active Core module in AMLs demon-
strated to have high LSC frequency (MLL-ENL and MLL-AF9)
(Figure 6A). In contrast, we observed active Mycmodule expres-
sion in high-frequency LSC AMLs (MLL-ENL and MLL-AF9), but
not in low-frequency LSC AMLs (MLL-AF10, MLL-AF1p, and
MLL-GAS7) or control.
It has been reported that the previously defined ESC-like gene
module (Wong et al., 2008a) is prominent in a MLL-AF10
leukemia cell population enriched for LSCs (c-kit high) as
compared to c-kit low cells (Somervaille et al., 2009). As shown
in Figure 6B, we observed a stronger Myc module activity in the
LSC-enriched population. However, this cell population shows
relatively inactive Core module activity. In both of the tests
shown in Figure 6A and Figure 6B, we observed that the activity320 Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc.of the previously defined ESC-like gene module (Wong et al.,
2008a) is similar to the activity of the Myc module rather than
the Core module. If the gene expression findings are functionally
relevant to self-renewal of LSCs, our findings undermine the
notion that reactivation of an ESC-like pattern is critical for
LSCs in this setting. In contrast, Myc module activity alone
appears to correlate with LSC frequency in mouse AML models.
Core module activity does not appear to be a major determinant
of LSC frequency in AML.
ES Cell Modules in Human Cancers
To test the activity of ES cell modules more generally, we tested
module activity in gene expression profiles acquired from human
bladder carcinoma samples, including superficial and invasive
carcinomas, as well as a control group of normal urinary tract
cells (Sanchez-Carbayo et al., 2006). Figure 7A represents
each module activity from total 157 patient samples (each
column). Figure 7B represents combined module activity from
different groups of patient samples. In both superficial and inva-
sive carcinomas, the Mycmodule is more active compared to its
level of activity in control samples. However, the Core module
activity is repressed in both grades of cancers. Of note, we
observed a more active Myc module in superficial carcinoma
samples compared to more advanced stage of invasive carci-
noma samples. Heterogeneity of invasive carcinoma samples
may underlie this observation, or the active Myc module may
be critical in initiating invasive behavior, not necessarily active
afterward. Importantly, the previously defined ESC-like gene
module activity is again similar to the activity of the Myc module.
However, the Core module seems to be even more repressed in
carcinoma samples compared to control group (Figure 7A and
Figure 7B).
We next tested module activity within a human primary breast
cancer expression data set (van’t Veer et al., 2002) containing
fifty eight samples from patients who developed distant metas-
tases within 5 years (poor prognosis group), and 39 samples
from patients who continued to be disease free for at least
5 years (good prognosis group). First, we calculated Core
module activity of all samples and further analyzed samples
showing the strongest Core module activity (top 20% of
samples; n = 19), and the weakest Core module activity (bottom
20%; n = 19). As shown in Figure 7C and Figure 7E, no correla-
tion was observed between Core module activity and patient
outcome (interval to metastasis). On the other hand, Mycmodule
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Figure 7. ES Cell Modules in Human Cancers
(A and B) Average gene expression values (log2) of ES cell modules and previously defined ESC-like module are tested in human bladder carcinoma samples
including superficial (SUP), and invasive carcinomas (INV), as well as normal urothelium (NU) as a control group (marked by black bars) (Sanchez-Carbayo
et al., 2006). Each column represents one patient sample (total 157 samples) (A). Averaged module activities within the sample group (NU, INV, and SUP) (B).
Data are represented as mean ± SEM.
(C–E) Average gene expression values (log2) of ES cell Core (C) and Myc (D) module are tested from 97 human breast cancer patient samples (van’t Veer et al.,
2002). (C) Core module activities were calculated, and top and bottom 20% of samples (19 samples each) were further analyzed. Bar graph represents the
corresponding interval to metastases (months, bottom panel). (D) Samples showing top and bottom 20%ofMycmodule activity were further analyzed. Bar graph
represents the corresponding interval tometastases (months) for each patient (bottom panel). (E) For each tested group (C andD), interval to distant metastases is
calculated as mean ± SEM, and p values are from Student’s t tests. See also Figure S5.activity correlates positively with a poor prognosis (Figure 7D).
On average, metastasis occurs within 47 months in breast
cancer patients with strong Myc module activity (top 20%;
n = 19). In contrast, it took on average 89 months for the patients
with weak Myc module activity (bottom 20%) to progress to
metastasis (Figure 7E), suggesting that Myc module activity
predicts patient outcome.We observed that Mycmodule activity
in human breast cancer patient samples is very similar to the
previously defined ESC-like modules (Wong et al., 2008a)
(Figure S5A). Additional analyses using independent breast
cancer data sets also revealed that tumor samples with a more
active Myc module tend to be highly proliferative basal-like
tumors (Figures S5B, S5C, and S5E, middle panel) or ER nega-tive tumors (Figure S5D and S5E, left panel). These results are
consistent with findings of others demonstrating a correlation
of Myc activity with poor outcome in breast cancer (Wolfer
et al., 2010). Interestingly, we observed that highly proliferative
cells show stronger Myc module activity (Figure 6, Figure 7,
Figure S4, and Figure S5), suggesting a link between the Myc
module activity and cell proliferation.
DISCUSSION
By integrating protein-protein interaction and protein-DNA inter-
action studies, we constructed a Myc-centered transcriptional
regulatory network in an effort to complement the previouslyCell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc. 321
identified core regulatory and Polycomb networks in ES cells.
Our approach, analyzed together with data of others, delineates
three major transcriptional regulatory subnetworks in ES cells.
On the basis of the target co-occupancy of factors in each
network, we defined three functionally separable regulatory
modules (Figure 4 and Figure 5) and showed that the overall
ES cell gene transcription program can be subdivided largely
into functionally independent regulatory units.
It is interesting to note that a previous RNAi-based screen
revealed that members of the NuA4 HAT complex (or Tip40-
Ep400 complex) are critical in ES cell identity (Fazzio et al.,
2008). Upon knockdown of some of NuA4 HAT complex pro-
teins, as well as Myc, we also observed that ES cells display
flattened morphology (Figure S1E). Of note, knockdown of
Ep400 or Dmap1 did not change the expression level of Oct4
and Nanog proteins, nor did knockdown of Nanog change the
protein level of Ep400 and Dmap1 (Fazzio et al., 2008; see also
Figure S1D). These data support the conclusion that the Core
and Myc-centered subnetworks in ES cells are separable units
with unique roles in maintaining ES cell self-renewal.
Previous studies have suggested that Myc is critical at an
early stage in somatic cell reprogramming (Sridharan et al.,
2009). Our work suggests that, beyond Myc itself, reactivation
of a larger module composed of more than 500 genes is critical
to achieve partially or fully reprogrammed stem cell–like cells. It
is particularly interesting that the Core module, which is
composed of more than 100 genes, remains inactive in piPS
cells, again implying that the reactivation of an entire functional
module by a limited set of factors is critical to achieving
induced pluripotency. It will be of interest to determine whether
specific small molecules or genes selectively modulate the
activity of the ES cell modules in efforts to identify new chem-
icals or factors not only for replacing Myc or other factors in
somatic cell reprogramming, but also for selection of putative
therapeutic targets in cancer. Because Myc interacts with
NuA4 complex proteins in ES cells, recruitment of the NuA4
HAT complex by Myc may be a critical step in somatic cell
reprogramming.
The relationship between ES cell and cancer signatures has
been a focus of attention given that self-renewal is a hallmark
of both cell types. It has been proposed that the activation of
an ESC-like gene expression program in adult cells may confer
self-renewal to cancer cells or cancer stem cells (Ben-Porath
et al., 2008; Wong et al., 2008a). It is noteworthy that we
observed very similar patterns of module activity between our
Myc module and the previously defined ESC-likes (Core ESC-
like gene module and mouse ESC-like gene module) (Wong
et al., 2008a), but not with our Core module, in situations we
tested. In accordance with this observation, approximately
60% of genes in the previously defined Core ESC-like module
(Wong et al., 2008a) are Myc targets that we identified (Kim
et al., 2008). Notably, 57% of genes in the Core ESC-like module
(Wong et al., 2008a) are common targets of at least five factors
among seven factors in the Myc cluster (Figure 4). In contrast,
less than 2% of genes in the previously defined ESC-like module
are shared with the Core module. These findings argue that the
previously described ESC-like module (Wong et al., 2008a)
conveys information largely contributed by the Myc module,322 Cell 143, 313–324, October 15, 2010 ª2010 Elsevier Inc.and, conversely, that the ESC-like module is quite distinct from
the Core module. The simple interpretation that the presence
of ESC-like module activity in cancer reflects dedifferentiation
or regression to an embryonic or ES-like state (Wong et al.,
2008a) is inconsistent with our analysis.
In their recent work, Ben-Porath et al. (2008) compiled 13
partially overlapping gene sets belonging to four groups (ES-ex-
pressed, active NOS [Nanog, Oct4, and Sox2] targets, Polycomb
targets, and Myc targets) that are similar to the modules utilized
in our analysis. They showed that poorly differentiated tumors
show preferential expression of ES cell–specific genes, in
addition to preferential repression of Polycomb target genes.
Interestingly, their analysis revealed that ES-expressed and
Polycomb-target sets show the most significant degree of
enrichment in most tumors, whereas the other gene sets are
not a major determinant of their ES cell-like gene expression
signature. Of special note, we find that 38% and 52% genes in
their ES-expressed gene sets (ES exp1 and ES exp2, respec-
tively) contain the common targets of at least five factors among
seven factors in the Myc cluster, suggesting that a large portion
of genes in their ES-expressed gene sets are, in turn, Myc-
related genes. It is noteworthy that the PRC module defined in
ES cells is also largely repressed in most cancers we tested,
suggesting a role of Polycomb complex proteins and their
targets in cancer initiation and/or progression.
Our analysis is conceptually different from prior approaches in
that we have stringently defined regulatory modules based on
common gene targets of multiple factors. By use of this strategy,
we have defined modules that serve as powerful analytical tools
to interrogate different cellular states and the relatedness of
gene expression signatures of ES cells and cancers. Reanalysis
of prior data sets in this manner raises concern regarding the
hypothesis that cancer cells, or cancer stem cells, recapitulate
regulatory programs characteristic of embryonic stem cells. As
a unifying view, the hypothesis is attractive and has gained
considerable attention in recent literature. Nonetheless, our
findings should temper enthusiasm and stimulate further reas-
sessment of these issues. Moreover, our findings reemphasize
the critical nature of regulatory pathways controlled by Myc in
cancer.EXPERIMENTAL PROCEDURES
ES Cell Lines and Culture
Mouse J1 ES cell lines were maintained in ES medium as documented in
Supplemental Information.Protein Complex Pull-Down and Mass Spectrometry
One-step affinity purification and protein complex identification using nuclear
extracts from ES cell lines expressing BirA only (reference) or both BirA- and
biotin-tagged proteins (sample) with streptavidin-agarose were performed
as described elsewhere (Kim et al., 2009; Wang et al., 2006). Further details
are documented in Supplemental Information.ChIP-chip
At least three biological replicates of ChIP and bioChIP reactions were per-
formed for each factor, as described elsewhere (Kim et al., 2009; Kim et al.,
2008). Detailed procedure and a list of antibodies used for native antibody
ChIP reactions are available in Supplemental Information.
Microarray and Data Processing
Amplification of ChIP samples and microarray hybridizations were performed
as described elsewhere (Kim et al., 2008).
ACCESSION NUMBERS
The raw and processed ChIP-chip data set can be found on the public server
GEOunder the accession number of GSE20551. Further details are available in
Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures,
five figures, and three tables and can be found with this article online at
doi:10.1016/j.cell.2010.09.010.
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